None listed
Conditions
Interventions
50 participants will receive two series of injections in two separate appointments with at least one week between sessions, administered by the same operator. The target site for injection will be the
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Participants between the age of 18-60 years old ASA ?,?? classification
Exclusion criteria
Exclusion criteria: Pregnancy Allergy to articaine History of depression Use of CNS suppressing drugs for 24 hours before the study Inability to provide full and willing consent to participate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reading percentage of EPT number 64/64. Timepoint: Immediately after performing all infiltrations, a timer will be used to measure the elapsed time of the anesthetic injection. Then, the EPT device is used every three minutes for 60 minutes, starting from minute one, to evaluate the level of pulp numbness. Every three minutes, the opposite maxillary canine was also tested to confirm that the participants were responding correctly. Method of measurement: Electric pulp tester (EPT).;Pain score at different stages of injection by visual analog scale. Timepoint: A 170mm Visual Analogue Scale (VAS) Heft parker 170 will be used to assess participants' pain during insertion, placement, solution deposition, real and mock infiltration anesthesia. Method of measurement: Visual Analogue Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| . Timepoint: . Method of measurement: . | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFereshteh Sobhnamayan
Shiraz University of Medical Sciences
Outcome results
None listed